Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Minority Interest (2016 - 2025)

Fortress Biotech has reported Minority Interest over the past 11 years, most recently at $12.3 million for Q4 2025.

  • Quarterly results put Minority Interest at $12.3 million for Q4 2025, up 150.49% from a year ago — trailing twelve months through Dec 2025 was $12.3 million (up 150.49% YoY), and the annual figure for FY2025 was $12.3 million, up 150.49%.
  • Minority Interest for Q4 2025 was $12.3 million at Fortress Biotech, up from $9.3 million in the prior quarter.
  • Over the last five years, Minority Interest for FBIO hit a ceiling of $140.0 million in Q2 2021 and a floor of -$34.5 million in Q2 2023.
  • Median Minority Interest over the past 5 years was $8.8 million (2022), compared with a mean of $26.7 million.
  • Biggest five-year swings in Minority Interest: surged 263.46% in 2021 and later tumbled 352.37% in 2023.
  • Fortress Biotech's Minority Interest stood at $117.2 million in 2021, then tumbled by 92.91% to $8.3 million in 2022, then tumbled by 352.37% to -$21.0 million in 2023, then decreased by 16.34% to -$24.4 million in 2024, then soared by 150.49% to $12.3 million in 2025.
  • The last three reported values for Minority Interest were $12.3 million (Q4 2025), $9.3 million (Q3 2025), and -$6.5 million (Q2 2025) per Business Quant data.